Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » PMS-Fingolimod


Contraindicated
Congenital malformations

Contraindicated
PMS-Fingolimod :
Type Medicine Authorised
Originator Gilenya
Agent UPO
Distributor UPO
Laboratory Pharmascience
Responsible Party Pharmascience Inc
Origin Canada
Manufacturer Pharmascience Inc
Manufacturing Type G
Origin Canada
ATC L04AA27

Your comment will appear shortly after approval

PMS-Fingolimod :

Revision Date : 21/05/2015


Effect Frequency
Acute disseminated encephalomyelitis Not known
Alopecia Common
ALT increased Very Common
AST increased Very Common
Asthenia Common
Atrioventricular block (AVB) Common
B-cell lymphoma Not known
Back pain Very Common
Blood triglycerides increased Common
Bradyarrhythmia Not known
Bradycardia Common
Bronchitis Common
Carbon monoxide diffusing capacity decreased Not known
Cardiac arrest Not known
Cough Very Common
Cryptococcosis Not known
Death Not known
Depressed mood Uncommon
Depression Common
Diarrhoea (Diarrhea) Very Common
Dizziness Common
Dyspnoea (dyspnea) Common
Eczema Common
Epstein-Barr virus associated lymphoma Not known
Forced expiratory volume decreased Not known
Gamma-GT increased Very Common
Haemorrhagic stroke Not known
Headache Very Common
Hepatic enzyme increased Very Common
Herpes virus infection Common
Histiocytosis haematophagic Not known
Hypersensitivity Not known
Hypertension Common
Infection Not known
Influenza-like illness Very Common
Ischaemic stroke Not known
Leucopenia (Leukopenia) Common
Lower respiratory tract infection Common
Lymphoma Not known
Lymphopenia Common
Macular oedema Uncommon
Meningitis cryptococcal Not known
Migraine Common
Neutrophil count decreased Uncommon
Peripheral arterial occlusive disease Not known
Pneumonia Uncommon
Posterior reversible leukoencephalopathy syndrome (PRES) Rare
Pruritus Common
Sinusitis Very Common
Skin rash Not known
T-cell lymphoma Not known
Tinea infection Common
Tinea versicolour Common
Vision blurred Common
Visual acuity reduced Not known

Different Units By MoH Code

Revision Date : 10/02/2020

Revision Date : 10/02/2020

PMS-Fingolimod  MoH 10373 :
Form Capsule
Package Size Box of 28
Strength 0.5mg
Storage Condition 15-30°C Away from moisture
Public Price 19351580,35 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 25020/1
Submission date 25/02/2020
Registration Year 02/10/2020
Pending Year 02/10/2020


Price Comparison

● Country: Lebanon
● Form: Capsule
● Package Size: Box of 28
● Public Price: 19351580.35 LBP ( 19,351,580.35 LBP )
● Pack size unit used: 28
● Cost/Unit: 691127,87 LBP ( 691,127.00 LBP )
● Pricing Date: 10/11/2025

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info